Transgene Biotek Share Price
11 Nov, 2026 4:01 PM (IST)
Transgene Biotek Performance
- Today's Low
- ₹3
- Today's High
- ₹3
- 52 Week Low
- ₹2
- 52 Week High
- ₹4
- Open Price₹3
- Previous Close₹3
- Volume15,576
- 50 DMA₹2.60
- 100 DMA₹2.70
- 200 DMA₹2.90
Transgene Biotek Chart
Investment Returns
- Over 1 Month + 6.48%
- Over 3 Month -10.54%
- Over 6 Month -15.16%
- Over 1 Year -31.51%
Smart Investing Starts Here Start SIP with Transgene Biotek for Steady Growth!
Transgene Biotek Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -12.4
- PEG Ratio
- 0.5
- Market Cap Cr
- 20
- P/B Ratio
- 2.5
- Average True Range
- 0.3
- EPS
- -0.2
- Dividend Yield
- 0
- MACD Signal
- -
- RSI
- 53.85
- MFI
- 61.07
Latest Stock News Updates
Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve To consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half yearly ended September 30, 2026.
- BSE India
- 4 days 10 hours ago
1. RESIGNATION OF M/S. HARISH GUMMADI & CO., CHARTERED ACCOUNTANTS: The Board took note of the resignation letter dated 03rd November, 2026, submitted by M/s. Harish Gummadi & Co., Chartered Accountants (Firm Registration No. 023771S), represented by Mr. Harish Gummadi, Partner (Membership No. 232447), resigning from the position of Statutory Auditors of the Company with effect from 03rd November, 2026. 2. APPOINTMENT OF M/S. RANGANATH PRASAD & CO., STATUTORY AUDITORS TO FILL THE CASUAL VACANCY: The Board of Directors, based on the recommendation of the Audit Committee, has approved the appointment of M/s Ranganath Prasad & Co., Chartered Accountants as the Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of the previous Statutory Auditors, M/s. Harish Gummadi & Co., Chartered Accountants
- BSE India
- 1 week ago
Intimation of Resignation of Statutory of Auditors - M/S. Harish Gummadi & Co.., Chartered Accountants.
- BSE India
- 1 week ago
Transgene Biotek Financials
Transgene Biotek Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹2.50
- 50 Day
- ₹2.60
- 100 Day
- ₹2.70
- 200 Day
- ₹2.90
Resistance and Support
- R3 2.80
- R2 2.80
- R1 2.70
- S1 2.50
- S2 2.50
- S3 2.40
Transgene Biotek Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-13 | Quarterly Results | |
| 2026-10-10 | Others | Inter alia, (1) To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company. |
| 2026-08-07 | Quarterly Results & Others | |
| 2026-05-29 | Audited Results | |
| 2026-02-13 | Quarterly Results |
About Transgene Biotek
Transgene Biotek is an Indian public biotech firm, established in 1990, focused on R&D for vaccines, oncology, biogenerics, and novel drug delivery (oral/nasal proteins/peptides) for unmet needs, exporting to various global markets and developing treatments for cancer, auto-immune issues, etc View More- NSE Symbol
- TRABI
- BSE Symbol
- 526139
- ISIN
- INE773D01018
Similar Stocks to Transgene Biotek
Popular Stocks
Transgene Biotek FAQs
Transgene Biotek share price is ₹2 As on 12 November, 2026 | 03:26
The Market Cap of Transgene Biotek is ₹19.9 Cr As on 12 November, 2026 | 03:26
The P/E ratio of Transgene Biotek is -12.4 As on 12 November, 2026 | 03:26
The PB ratio of Transgene Biotek is 2.5 As on 12 November, 2026 | 03:26
The 52 week High & Low of Transgene Biotek is ₹4.2/₹1.8 respectively As on 12 November, 2026 | 03:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.